 CymaBay Therapeutics, Inc. NASDAQ:CBAY Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Paul Quinlan - General Counsel Sujal Shah - Chief Executive Officer Dan Menold - Vice President, Finance Charles McWherter - Chief Scientific Officer Conference Call Participants Steven Seedhouse - Raymond James Patrick Dolezal - LifeSci Capital Ed Arce - H.C. Wainwright Jay Olson - Oppenheimer Company Michael Kratky - SVB Securities Operator Good day, ladies and gentlemen and welcome to the CymaBays First Quarter 2022 Financial Results and Business Update Conference Call. 